Apr 01, 2020 - Here we provide three stocks from the drug and biotech sector which can offer protection to an investor's portfolio amid stock market turmoil due to coronavirus crisis.
Apr 06, 2020 - Today's episode of Full Court Finance here at Zacks quickly dives into why Wall Street seems optimistic on Monday. Despite the positivity, investors should still be on the hunt for stocks that appear immune to the broader coronavirus fallout...
Apr 08, 2020 - The S&P 500's average daily percentage price change over the past five weeks has been plus or minus 4.8%. This explains why the Cboe Volatility Index remains elevated at around the 40s.
Apr 09, 2020 - Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Apr 13, 2020 - Zacks.com featured highlights include: Electromed, NovaGold Resources, FTI Consulting, Eli Lilly and Masimo
Apr 14, 2020 - SNY vs. LLY: Which Stock Is the Better Value Option?
Apr 16, 2020 - CytoDyn (CYDY) treats first patient in a phase IIb/III study evaluating leronlimab in severe and critically ill COVID-19 patients. A phase II study on leronlimab shows encouraging results in mild-to-moderate COVID-19 patients.
Apr 20, 2020 - Ericsson's (ERIC) first-quarter performance is likely to have benefited from momentum in business led by its strategy to increase investments for technology leadership, including 5G.
Apr 21, 2020 - Q1 Earnings Scorecard and Analyst Reports for Exxon, Oracle & Eli Lilly
Apr 21, 2020 - Investor focus is likely to be on the impact of the coronavirus outbreak on Lilly's (LLY) performance when it reports first-quarter results.